Glenmark Pharmaceuticals USA launches Travoprost Ophthalmic Solution USP, 0.004%
Glenmark's Travoprost Ophthalmic Solution USP, 0.004% is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004% of Sandoz